Screening for lung cancer with low-dose computed tomography (CT) was the most beneficial in people who had the highest likelihood of dying from the disease, according to data taken from participants in the National Lung Screening Trial (NLST).
Screening for lung cancer with low-dose computed tomography (CT) was the most beneficial in people who had the highest likelihood of dying from the disease, according to data taken from participants in the National Lung Screening Trial (NLST).